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Background: Approximately 20,000 people have a transient ischemic attack (TIA) and 23,375 have a minor stroke in
England each year. Fatigue, psychological and cognitive impairments are well documented post-stroke. Evidence
suggests that TIA and minor stroke patients also experience these impairments; however, they are not routinely
offered relevant treatment. This systematic review aims to: (1) establish the prevalence of fatigue, anxiety,
depression, post-traumatic stress disorder (PTSD) and cognitive impairment following TIA and minor stroke and to
investigate the temporal course of these impairments; (2) explore impact on quality of life (QoL), change in
emotions and return to work; (3) identify where further research is required and to potentially inform an
intervention study.
Methods/Design: A systematic review of MEDLINE, EMBASE, PsycINFO, CINAHL, Cochrane libraries and grey
literature between January 1993 and April 2013 will be undertaken. Two reviewers will conduct screening search
results, study selection, data extraction and quality assessment. Studies of adult TIA and minor stroke participants
containing any of the outcomes of interest; fatigue, anxiety, depression, PTSD or cognitive impairment will be
included. Studies at any time period after TIA/minor stroke, including those with any length of follow-up, will be
included to investigate the temporal course of impairments. QoL, change in emotions and return to work will also
be documented. The proportion of TIA or minor stroke participants experiencing each outcome will be reported.
If appropriate, a meta-analysis will pool results of individual outcomes. Studies will be grouped and analyzed
according to their follow-up timeframe into short-term (< 3 months after TIA/minor stroke), medium-term (3 to 12
months) and long term (> 12 months). Sub-analysis of studies with a suitable control group will be conducted.
Exploratory sub-analysis of memory and attention domains of cognitive impairment will be conducted.
Discussion: The current treatment goal for TIA and minor stroke patients is secondary stroke prevention. If these
patients do experience fatigue, psychological or cognitive impairments then this treatment alone is unlikely to be
sufficient. The results of this comprehensive review will increase understanding of treatment needs for this patient
group, identify where further research is required and potentially inform an intervention trial.
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Stroke is caused by an impaired supply of blood to the
brain resulting in loss of brain function, and is one of
the major causes of mortality and functional disability in
the United Kingdom (UK) [1,2]. The severity of strokes
differ between patients and can be classified as major
stroke, minor stroke and transient ischemic attack (TIA),
also known as mini-stroke. The term major stroke broadly
refers to strokes that result in long-term or permanent
neurological symptoms and may result in disability. Minor
stroke is a term that is widely used in research but has not
been formally defined, however, it refers to strokes with
symptoms lasting longer than 24 hours but where symp-
toms are mild and non-disabling [3]. TIA is defined by
stroke-like symptoms typically lasting less than one hour
and no evidence of acute infarction [4]. TIA and minor
stroke also create a substantial burden on society and
affect a huge proportion of the population. In England, ap-
proximately 20,000 people have a TIA and 23,375 people
have a minor stroke every year [5].
Fatigue, cognitive and psychological problems after stroke
In addition to functional disability, sequelae following
stroke include fatigue, cognitive impairments and psycho-
logical impairments, such as anxiety, depression and post-
traumatic stress disorder (PTSD) [6]. These impairments
are documented in the literature and have a detrimental
impact on people’s lives [7-10]. Fatigue is multidimen-
sional and comprises physical, emotional and cognitive el-
ements [11]. Fatigue has been shown to impact on stroke
survivors’ rehabilitation and quality of life (QoL) [12] and
is associated with depression [13], inability to return to
work [14] and increased fatality post-stroke [15]. The bur-
den of fatigue should not be underestimated, for instance
one study found 40% of stroke patients reported fatigue as
their worst symptom [16].
Anxiety is universally the most common mental health
disorder and is coupled with physical, behavioral and cog-
nitive symptoms [17]. Anxiety and depression frequently
occur simultaneously and, in this circumstance, depres-
sion is more severe and patients experience higher levels
of functional and cognitive impairment [17]. Both major
and minor depression have been documented post-stroke
and can occur at any time point from the acute stage up
to five years post-stroke with an estimated prevalence of
33% [18]. In addition, Ayerbe et al. reported that a high
proportion of patients with depression post-stroke at one
time point remained depressed [19]. Depression is associ-
ated with a poor prognosis, decreased QoL and increased
mortality [20].
PTSD can develop after exposure to a life-threatening
medical event and has been documented post-stroke [21].
Research has shown that occurrence of post-stroke PTSD is
independent of physical disability [8]. PTSD has detrimentalimplications and patients with PTSD have been shown to
have an increased risk for a worse physical and mental
health prognosis and have greater suicidal intention [8]. It
is speculated that a poor health prognosis related to PTSD
is associated with both biological mechanisms, such as
high blood pressure, and behavioral factors, such as non-
adherence to medication [22]. Resultant non-adherence to
medication may impact on stroke and TIA survivors as this
is essential for secondary prevention of stroke. PTSD also
adversely affects people’s QoL and normal functioning [23].
Conversely, life-threatening events can also produce a posi-
tive psychological change known as post-traumatic growth.
McGrath and Linley [24] reported evidence of sustained
positive psychological change after acquired brain injury.
However the sample size for this study was small. Further-
more post-traumatic growth following stroke is reported to
be inversely correlated with anxiety and depression [25].
This concept is relatively new to stroke research and there
is only a small amount of literature available, which to our
knowledge has not yet been extended to TIA and minor
stroke. Therefore this review will be limited to PTSD.
Cognitive impairment is well documented following
stroke and exhibits a wide-range of symptoms including
difficulty with memory, reading, writing and number skills,
visual impairment and difficulty planning and problem
solving. A relationship between cognitive and functional
impairment has been reported along with a negative im-
pact on rehabilitative outcomes [26]. Cognitive impairment
is associated with depression but the directional relation-
ship is unclear [27]. For the purpose of this review, cogni-
tive impairment will encompass impairments of attention,
memory, spatial awareness, perception, apraxia and execu-
tive functioning as in accordance with the Royal College of
Physicians National Clinical Guidelines for Stroke [28].
Impairment after TIA and minor stroke
Fatigue, psychological and cognitive impairment have been
shown to occur post-stroke in the absence of functional im-
pairment and independent of stroke severity [29]. Although
TIA and minor stroke are characterized by short-lasting
symptoms, evidence suggests that this cohort experience
residual problems. Coutts et al. [30] found that 15% of a
sample of TIA and minor stroke patients were disabled at
90 days as defined by a modified Rankin Scale score ≥ 2.
Another study reported TIA patients to have comparable
QoL scores to stroke patients in all domains with the ex-
ception of social isolation [31]. However, results of this
study may be unrepresentative of the true stroke population
as stroke patients in rehabilitation hospitals and care homes
were excluded. Significant fatigue has been reported in a
community population of TIA and minor stroke patients
with a prevalence, at six months, of 29% and 56% respec-
tively [32]. Qualitative research of people’s experiences fol-
lowing TIA or minor stroke revealed that people reported a
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tional impairments, such as limb weakness and numbness;
cognitive impairments, such as memory difficulties; slurred
speech; emotional issues, such as feeling depressed, con-
fused and more emotional [34].
Current treatment guidelines relevant to TIA and minor
stroke focus on secondary prevention of stroke [5]. How-
ever, no consideration is given to psychological or cogni-
tive impacts of TIA or minor stroke and patients are not
routinely offered additional rehabilitative support. Un-
treated fatigue, psychological or cognitive impairment will
result in a reduced QoL and affect people’s ability to re-
turn to work and social activities.
Aims
Considering the diversity and complexity of residual im-
pairments anecdotally described by people following
TIA and minor stroke, it is important to conduct a com-
prehensive systematic review of the literature. This is a
necessary step to develop future intervention studies that
will inform treatment recommendations and guidelines.
This systematic review therefore aims to:
 Establish the prevalence of fatigue, anxiety,
depression, PTSD and cognitive impairment
following a TIA or minor stroke and investigate if
this prevalence changes over time.
 Explore the impact of TIA and minor stroke on
people’s QoL, change in emotions and return to work.
 Identify where there are gaps in the understanding
of residual problems after TIA and minor stroke.
Methods
Our search strategy, selection of studies, assessment of risk
of bias and reporting of results for the review will be
conducted in accordance with the Preferred Reporting
Items for Systematic Reviews and Meta-analyses (PRISMA)
statement [35]. This protocol is not registered with Pro-
spective Registering of Systematic Reviews (PROSPERO)
as the scope of the research does not meet their current in-
clusion criteria.
Eligibility criteria
The inclusion of studies in the systematic review will be de-
termined by participants, comparators, outcomes and study
designs used by the study and the report characteristics.
Participants
This review will include TIA and minor stroke partici-
pants. Studies will be excluded if they recruited major
stroke participants or mixed populations, where it is not
possible to extract the data of TIA or minor stroke par-
ticipants. As stroke is a confounding factor for outcomes
of interest, participants must have no previous history ofstroke and be stroke free in the follow-up period. Alter-
natively, the study must have subgroup analysis of stroke
free participants. Participants must be adults (over 18
years of age) to exclude childhood stroke. Studies that
include participants under 18 years of age will be in-
cluded if over 90% of the sample are adults.
There is not a standard definition of minor stroke
however, as suggested by Fischer et al. [3], this patient
group should have non-disabling symptoms following
stroke but be distinct from TIA patients. TIA patients
will be defined by short-lasting stroke symptoms (less than
24 hours) with no evidence of acute infarct. Studies where
authors describe their population as TIA, minor stroke,
mild stroke, reversible ischemic neurologic deficit or non-
disabling stroke will be included.
Comparators
Descriptive study designs will be included in this review
and, therefore, studies without a comparison group will
be included. However, if present, data will be extracted
for control groups where participants have no history of
stroke, minor stroke or TIA. Participants’ data on out-
comes before their TIA or minor stroke will also be used
as suitable a comparator.
Outcomes
Stroke causes a broad spectrum of impairments; anec-
dotal evidence from TIA and minor stroke patients em-
ulates these diverse impairments. Given this, exploratory
analysis will be conducted to identify the proportion of
TIA and minor stroke participants with the following; fa-
tigue, anxiety, depression, PTSD or cognitive impairment.
These principle outcomes will be defined by scores above
the predefined cut off limit for validated assessments.
Studies must either report the frequencies for outcomes
or data whereby frequencies can be calculated. There will
be no restrictions on the duration of participant follow-up
or time since TIA or minor stroke to develop understand-
ing about the temporal course of the outcomes. Informa-
tion on QoL, change in emotions and return to work or
performance at work will also be documented. Studies will
be included that report any of the above outcomes.
Study design
Initial scoping searches ascertained that a limited
amount of relevant studies have been conducted that in-
clude a comparator group. Therefore, all study designs
will be included with the exception of single case studies
and reviews. Intervention studies may be included if the
non-intervention arm consists of TIA or minor stroke
patients receiving usual care. Only data from this control
arm will be analyzed as this review is not investigating
interventions.
Table 1 The inclusion checklist for screened references
Study design Cross sectional
Cohort
Case control
Case series
Other (please specify)
Study objectives relevant to topic
Report characteristics Full article
Conference abstract
Thesis
Other (please specify)
Publication date 1993 to 2003
Participants TIA
Minor stroke
Study sample are adults
Participants have no previous history of
stroke/subgroup analysis of those with
no history of stroke
Participants stoke free during follow-up/
subgroup analysis of those stroke free
Comparator (Do NOT exclude
if no comparator)
Comparator group present?
(If no, go to outcomes)
No previous history of stroke,
minor stroke or TIA
Outcomes Measure for anxiety
Measure for depression
Measure for fatigue
Measure for PTSD
Measure for cognition
Quality of life reported
Change in emotions reported
Return to work reported
Frequencies reported/can be calculated
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Only human studies will be included. Full papers, con-
ference abstracts and theses will be included. To avoid
language bias, non-English papers will be included. For
pragmatic and quality of reporting reasons, the review
will limit the search to 20 years (1993 to 2013).
Information sources
Electronic searches of the following databases will be
conducted; MEDLINE, EMBASE, PsycINFO, Cumulative
Index to Nursing and Allied Health Literature (CINAHL),
Database of Abstracts of Reviews of Effects (DARE), the
Cochrane Central Register of Controlled Trials (CEN-
TRAL) and Cochrane Database of Systematic Reviews
(CDSR). Databases will be searched from January 1993 to
April 2013.
Ongoing studies will be identified by searching
clinicaltrials.gov, Stroke Trials Registry (www.strokecen
ter.org/trials/) and conference abstracts including the
American Heart Association International Stroke confer-
ence, European Stroke conference and UK Stroke Forum.
Conference Proceedings Citation Index (CPCI) will also
be searched for conference abstracts. These sources will
be searched from 2010 to 2013 as it will be assumed stud-
ies presented before these dates will have been completed
and published.
Grey literature will be explored including PubliCAT and
ScienceDaily.com. The first four pages of Google Scholar
results will be searched; this limit was established from
scoping searches. Dissertations and theses will be identi-
fied from the databases ProQuest Dissertation Thesis
Database and thesis.com. References from included stud-
ies will be scanned and tracked through the cited refer-
ence search in Science Citation Index (SCI).
Search
A comprehensive search strategy has been developed that
focuses on the following elements; TIA, minor stroke, fa-
tigue, anxiety, depression, PTSD and cognitive impair-
ment. Search terms have been established by scoping
searches. The MEDLINE search strategy is detailed in
Additional file 1. This search will be adapted for the other
databases.
Study selection
The titles and abstracts of the search results will be
screened and full text will be obtained for relevant stud-
ies. Two authors (GT and BF) will complete this process
independently and any difference in opinion will be re-
solved by a third reviewer (TM). Full text articles will be
reviewed to determine if studies included through screen-
ing meet the inclusion criteria. An inclusion checklist has
been developed, based on the eligibility criteria, and piloted
(Table 1).Data collection process
Data extraction will be performed in duplicate by two
independent reviewers (GT and BF) for all of the eligible
papers identified through the screening process. A data
extraction form has been developed which focuses on
population, comparator, outcomes and study design. This
form has been informed by the STROBE (STrengthening
the Reporting of OBservational studies in Epidemiology)
statement [36]. The data extraction form was piloted inde-
pendently by two researchers (GT and MF) on known pa-
pers. A Microsoft Excel document will be used to manage
the data extraction.
Quality assessment
Quality assessment of included studies will be performed
by two independent reviewers (GT and BF). A quality
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sampling, measurement of outcomes, attrition and ana-
lysis (Table 2). This form has been piloted independently
by two researchers on known papers (GT and MF). In
accordance with the Cochrane Collaboration recommen-
dations, an overall score will not be generated but a risk
of bias judgment of ‘yes’, ‘no’ or ‘unclear’ will be given
for individual domains [37]. The studies level of quality
will be presented in a table and narrative summary. The
impact of the studies quality on results will be evaluated
in the discussion. If appropriate, a sensitivity analysis will
be conducted excluding poor quality studies.
Synthesis and analysis of results
If the outcomes demonstrate homogeneity, the results
for individual outcomes will be pooled quantitatively using
meta-analysis. The temporal course of fatigue, psycho-
logical and cognitive impairment post-stroke has not been
well characterized. However, prevalence of post-stroke de-
pression has been shown to have immediate onset, peak at
three to six months but also remain high years after stroke
[38]. To explore the time course of these impairments fol-
lowing TIA and minor stroke, studies will be grouped into
short-term (less than three months after TIA or minor
stroke), medium-term (three to twelve months) and long-Table 2 The quality assessment criteria for included studies
Sampling Was the study design appropriate to answer the
Was the sampling method appropriate?
Did the study report how many people were ap
many agreed to take part?
Do those that participate have similar characteri
(for example, age, gender, comorbidities, how th
Is the sample size adequate?
Did the study describe how the sample size was
Was a suitable definition of TIA/minor stroke use
If applicable, was the control group comparable
recruitment and baseline characteristics)?
Did the study demonstrate if the outcomes wer
TIA/minor stroke (for example, history of depress
Measurement Was a suitable measurement for outcome used?
Has the outcome measure been validated for th
Was the outcome measure cut-off score predefin
Was the outcome measure administration suitab
investigator interview)?
Were potential confounding variables measured
Attrition Were numbers of dropouts/withdrawals docume
Were reasons given for dropouts/withdrawals?
Analysis Were all outcomes reported?
Were confounding variables adjusted for?term (over twelve months). If appropriate, frequencies for
each outcome will be combined to create pooled estimates
for short, medium and long term timeframes.
A sub-analysis of studies with a suitable control group
will also be conducted to determine whether outcome pro-
portions are higher in TIA and minor stroke patients com-
pared to healthy controls. Cognitive impairment covers a
spectrum of different domains. Anecdotal evidence suggests
that TIA and minor stroke patients experience residual
memory and attention complaints. Therefore, exploratory
analysis of specifically memory and attention domains of
cognitive impairment will be conducted. To investigate
the natural history of fatigue, psychological and cognitive
impairment after TIA and minor stroke, exploratory ana-
lysis of the outcomes for new cases compared to persistent
cases will be conducted for studies with more than one
time point.
If studies are methodologically heterogeneous, a narra-
tive synthesis of results will be more appropriate. In ac-
cordance with the Center for Reviews and Dissemination
(CRD), included studies will be summarized in a table de-
tailing study type, sample size, participant characteristics,
outcomes and outcome measures [39]. The Economic and
Social Research Council (ESRC) guidance report will be
used as a framework for a narrative synthesis [40].Judgment (yes/no/unclear)
Support for judgment
research question?
proached and how
stics to those that refused
ey were approached)?
determined?
d?
to cases (consider suitability,
e present before the
ion)?
e population?
ed?
le (for example, self reported,
?
nted at each time point?
Moran et al. Systematic Reviews 2013, 2:72 Page 6 of 7
http://www.systematicreviewsjournal.com/content/2/1/72Discussion
Currently the treatment goal for TIA and minor stroke
patients is the prevention of subsequent stroke [5]. These
patients are not acknowledged to have residual problems
which require management. This systematic review will
collate literature to establish whether evidence suggests
people experience fatigue, anxiety, depression, PTSD or
cognitive problems following a TIA or minor stroke. The
temporal nature of the prevalence of these impairments
after the event will also be investigated. In addition, im-
pact of TIA and minor stroke on QoL, change in emo-
tions and return to work will be explored. This systematic
review will identify if there is a lack of literature for any
of the outcomes and review the quality of the available
evidence.Implications of results
If it is found that TIA or minor stroke patients have an in-
creased prevalence of fatigue, psychological or cognitive
problems, then the current management, without address-
ing them, is unlikely to be adequate. Dissemination of re-
sults will increase the awareness of the treatment needs of
TIA and minor stroke survivors. This information will be
particularly valuable in the primary care setting where it is
likely that this patient group will present with residual
complaints.
The comprehensive and systematic search and review
of the literature will identify and inform where further
research is required. For instance, if a large number of
descriptive studies are available for the review, then the
findings will inform a subsequent analytical, hypothesis
testing, study. Alternatively, the findings from the review
might indicate that exploration research has already been
conducted and will therefore inform the design of an ac-
ceptability and feasibility study. This subsequent study will
investigate the effects of an intervention to manage and
treat fatigue, psychological and cognitive problems follow-
ing TIA and minor stroke.Additional file
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